Literature DB >> 26622387

Anti-neutrophil cytoplasmic antibody-negative microscopic polyangiitis: A case report and literature review.

Ran Wang1, Xiao-Chun Yang1, Si-Jing Zhou2, Geng-Yun Sun1.   

Abstract

The aim of this study was to investigate the clinical characteristics, diagnosis and treatment of anti-neutrophil cytoplasmic antibody (ANCA)-negative microscopic polyangiitis (MPA). We described the case of a patient with ANCA-negative MPA and conducted analyses and a review of the relevant literature. Based on the collected data, the epidemiology, diagnosis and treatment of ANCA-negative MPA were discussed. The patient, a 69-year-old male, was initially diagnosed with pneumonia and interstitial lung disease (ILD) based on his clinical symptoms. The patient was ANCA-negative. The follow-up and consultations with the relevant departments after the ANCA testing led to a diagnosis of MPA being considered. The administration of glucocorticoids and immunosuppressant drugs was found to improve the symptoms of the patient. The clinical symptoms of MPA are unspecific. The majority of MPA cases are ANCA-positive, but misdiagnosis should be considered as a possibility in ANCA-negative cases. When patients are suspected to have MPA, therefore, ANCA tests should be immediately performed. Test results should be analyzed for the early diagnosis of MPA in order to enable the provision of immediate treatment, improve patient prognosis and reduce mortality rate.

Entities:  

Keywords:  anti-neutrophil cytoplasmic antibody; glucocorticoids; microscopic polyangiitis

Year:  2015        PMID: 26622387      PMCID: PMC4509028          DOI: 10.3892/etm.2015.2523

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  14 in total

1.  Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis.

Authors:  Gregg M Eschun; Steven N Mink; Sat Sharma
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

Review 2.  Pulmonary involvement in microscopic polyangiitis.

Authors:  Christopher E Collins; Francisco P Quismorio
Journal:  Curr Opin Pulm Med       Date:  2005-09       Impact factor: 3.155

Review 3.  Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement.

Authors:  Aude Gibelin; Carla Maldini; Alfred Mahr
Journal:  Semin Respir Crit Care Med       Date:  2011-06-14       Impact factor: 3.119

4.  Microscopic polyangiitis: a large single-center series.

Authors:  Leslie Wilke; Marilynn Prince-Fiocco; Guy Peter Fiocco
Journal:  J Clin Rheumatol       Date:  2014-06       Impact factor: 3.517

5.  Microscopic polyangiitis.

Authors:  Lucy Smyth; Gillian Gaskin; Charles D Pusey
Journal:  Semin Respir Crit Care Med       Date:  2004-10       Impact factor: 3.119

6.  [An autopsy case of microscopic polyangiitis complicated with pulmonary aspergilloma and cytomegalovirus pneumonia].

Authors:  Shingo Kuboshima; Kayori Tsuruoka; Sayuri Shirai; Hiroyo Sasaki; Tsutomu Sakurada; Hiroshi Miura; Jun Okabayashi; Yusuke Konno; Yoshinori Shima; Takashi Yasuda; Takeo Sato; Kenjiro Kimura
Journal:  Nihon Jinzo Gakkai Shi       Date:  2007

Review 7.  Microscopic polyangiitis: Clinical presentation.

Authors:  Peter M Villiger; Loïc Guillevin
Journal:  Autoimmun Rev       Date:  2010-07-23       Impact factor: 9.754

8.  Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis.

Authors:  G E Tzelepis; M Kokosi; A Tzioufas; S P Toya; K A Boki; A Zormpala; H M Moutsopoulos
Journal:  Eur Respir J       Date:  2009-11-19       Impact factor: 16.671

9.  Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients.

Authors:  Min Chen; Feng Yu; Ying Zhang; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2008-07       Impact factor: 1.889

Review 10.  Epidemiology and clinical features of systemic vasculitis.

Authors:  David G I Scott; Richard A Watts
Journal:  Clin Exp Nephrol       Date:  2013-07-11       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.